drugset / Trial / NCT05429086

Explore the Advantages of Remimazolam Used on Gastroscopy

NCT05429086

Phase 4 Unknown 287 enrolled Sichuan Provincial People's Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

There are many different types of intravenous anesthetics used in gastroscopy, but each type of drug has its advantages and disadvantages,remimazolam is a novel ultra-short-acting benzodiazepine with rapid onset and recovery, low circulatory depression, and rapid reversal of sedation by flumazenil,remimazolam may be another relatively ideal sedative-hypnotic option for anesthesiologists and gastrointestinal endoscopists. The purpose of this study was to explore whether remimazolam combined with propofol is safer and more effective than remimazolam alone or propofol alone in gastrointestinal endoscopy.

Timeline

Start
2022-06
Primary completion
2022-08
Completion
2022-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 0.5 mg/kg Intravenous
Subject Remimazolam Small molecule 2.5 mg Intravenous

Indications

No indication recorded.